Rankings
▼
Calendar
ELAN FY 2024 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena
ELAN
Elanco Animal Health Incorporated
$12B
FY 2024 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$4.4B
+0.5% YoY
Gross Profit
$1.9B
43.0% margin
Operating Income
$251M
5.7% margin
Net Income
$338M
7.6% margin
EPS (Diluted)
$0.68
Cash Flow
Operating Cash Flow
$541M
Free Cash Flow
$394M
Stock-Based Comp.
$55M
Balance Sheet
Total Assets
$12.6B
Total Liabilities
$6.5B
Stockholders' Equity
$6.1B
Cash & Equivalents
$468M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.4B
$4.4B
+0.5%
Gross Profit
$1.9B
$1.9B
-1.5%
Operating Income
$251M
$326M
-23.0%
Net Income
$338M
-$1.2B
+127.5%
← Q4 2023
All Quarters
Q1 2024 →